Global Fluorine 18 Market Strategic Research Report

Scope of the Report

The global Fluorine 18 market size is predicted to grow from US$ 98 million in 2025 to US$ 157 million in 2032; it is expected to grow at a CAGR of 7.0% from 2026 to 2032.

Fluorine-18 is a radioisotope of fluorine that decays by positron emission with a half-life of approximately 109.8 minutes. Due to its relatively short half-life and the favorable physical characteristics of its decay, it is the most widely used radionuclide in Positron Emission Tomography (PET) scanning. It is frequently incorporated into radiopharmaceuticals, such as Fluorodeoxyglucose (FDG), to image metabolic activity in the human body, particularly for the diagnosis and staging of cancer and the evaluation of neurological disorders. In 2025, global Fluorine-18 production reached approximately 2 million GBq, and average price was 50 USD/GBq，with gross margin 60%

The global market for Fluorine-18 is currently undergoing a period of robust structural transformation, propelled by the convergence of personalized medicine, technological innovation in imaging, and an aging global population prone to oncological and neurological conditions. As the cornerstone radionuclide for Positron Emission Tomography (PET), Fluorine-18’s utility is underpinned by its near-ideal physical half-life of approximately 109.8 minutes, which balances the logistics of regional distribution with the clinical necessity for patient throughput.Market expansion is being fueled by several critical levers: first, the transition from traditional, glucose-based metabolism imaging (FDG) to highly specific, "smart" radiotracers targeting receptors such as PSMA for prostate cancer or amyloid plaques for Alzheimer’s disease. Second, the democratization of nuclear medicine is occurring through the deployment of decentralized, hospital-based medical cyclotrons, which mitigate supply chain bottlenecks inherent to short-lived isotopes. Third, the rise of the "theranostics" paradigm—linking diagnostic imaging with targeted radionuclide therapy—is cementing F18's role as a non-negotiable diagnostic pillar. While North America and Western Europe maintain market leadership due to high-tier reimbursement policies, the Asia-Pacific region is emerging as the primary engine for future growth, characterized by rapid infrastructure investment and a shift toward domestic radio-pharmaceutical manufacturing. Looking ahead, the integration of Artificial Intelligence for quantitative PET analysis and the standardization of automated radiochemistry modules are expected to further reduce operational costs and enhance diagnostic precision.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Fluorine 18 market?

What factors are driving Fluorine 18 market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Fluorine 18 market opportunities vary by end market size?

How does Fluorine 18 break out by Type, by Application?

This report presents a comprehensive overview of the global Fluorine 18 market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Nucleophilic Labeling
• Electrophilic Labeling

Segment by Bonding

• C-18F
• Si-18F
• B-18F

Segment by Specific Activity

• High Specific Activity
• Low Specific Activity

Segment by Application

• Medical Imaging
• Scientific Research

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Fluorine 18 market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Medical Imaging, Scientific Research evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact